TrialOrphanet journal of rare diseases2011

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen.

Ines Paule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.